Tumor-related hydrocephalus in infants: a narrative review

Childs Nerv Syst. 2021 Nov;37(11):3365-3373. doi: 10.1007/s00381-021-05142-7. Epub 2021 Mar 26.

Abstract

Primary brain tumors diagnosed during infancy present several challenges for the pediatric neurosurgeon including the management of tumor-related hydrocephalus. Infant tumor-related hydrocephalus (iTRH) is present in over 70% of new diagnoses overall and in over 90% of infants with infratentorial neoplasms. iTRH may be related to direct obstruction of cerebrospinal fluid (CSF) pathways, shedding of protein and/or cells leading to dysfunctional subarachnoid, tumor-related CSF production, or, most frequently, a combination of these mechanisms. Treatment plans must consider the acuity of presentation, the mechanism of iTRH, and the additional neoadjuvant or adjuvant therapies required to treat the neoplasm. This narrative review provides a broad reference on the epidemiology, pathophysiology, and treatment of iTRH.

Keywords: Central nervous system; Hydrocephalus; Infant; Neoplasm; Tumor.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms* / complications
  • Brain Neoplasms* / therapy
  • Child
  • Humans
  • Hydrocephalus* / etiology
  • Infant
  • Infratentorial Neoplasms*
  • Subarachnoid Space